Terms: = Pancreatic cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
26 results:
1. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR
Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288
[TBL] [Abstract] [Full Text] [Related]
2. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
[TBL] [Abstract] [Full Text] [Related]
3. Coinhibition of topoisomerase 1 and brd4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.
Cameron DP; Grosser J; Ladigan S; Kuzin V; Iliopoulou E; Wiegard A; Benredjem H; Jackson K; Liffers ST; Lueong S; Cheung PF; Vangala D; Pohl M; Viebahn R; Teschendorf C; Wolters H; Usta S; Geng K; Kutter C; Arsenian-Henriksson M; Siveke JT; Tannapfel A; Schmiegel W; Hahn SA; Baranello L
Sci Adv; 2023 Oct; 9(41):eadg5109. PubMed ID: 37831776
[TBL] [Abstract] [Full Text] [Related]
4. Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
Wilson GC; Patel SH; Wang J; Xu K; Turner KM; Becker KA; Carpinteiro A; Szabo I; Ahmad SA; Gulbins E
J Mol Med (Berl); 2023 Jul; 101(7):891-903. PubMed ID: 37246980
[TBL] [Abstract] [Full Text] [Related]
5. LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression.
Guo M; Zhuang H; Huang J; Shao X; Bai N; Li M; Niu M; Wei W; Sun L; Li Y; Qiang Z
Mol Cell Biochem; 2023 Sep; 478(9):1899-1914. PubMed ID: 36583796
[TBL] [Abstract] [Full Text] [Related]
6. Disease-related protein co-expression networks are associated with the prognosis of resectable node-positive pancreatic ductal adenocarcinoma.
Nishimura T; Takadate T; Maeda S; Suzuki T; Minowa T; Fukuda T; Bando Y; Unno M
Sci Rep; 2022 Aug; 12(1):14709. PubMed ID: 36038612
[TBL] [Abstract] [Full Text] [Related]
7. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract] [Full Text] [Related]
8. The optimal duration of capecitabine plus temozolomide in patients with well-differentiated pancreatic NETs with or without maintenance therapy.
Gao H; Dong J; Zhang W; Xu H; Ye L; Li H; Wang W; Liu L; Yu X
J Neuroendocrinol; 2022 Jun; 34(6):e13112. PubMed ID: 35380016
[TBL] [Abstract] [Full Text] [Related]
9. TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer.
Tu M; Klein L; Espinet E; Georgomanolis T; Wegwitz F; Li X; Urbach L; Danieli-Mackay A; Küffer S; Bojarczuk K; Mizi A; Günesdogan U; Chapuy B; Gu Z; Neesse A; Kishore U; Ströbel P; Hessmann E; Hahn SA; Trumpp A; Papantonis A; Ellenrieder V; Singh SK
Nat Cancer; 2021 Nov; 2(11):1185-1203. PubMed ID: 35122059
[TBL] [Abstract] [Full Text] [Related]
10. Pathologic Examination of pancreatic Specimens Resected for Treated pancreatic Ductal Adenocarcinoma: Recommendations From the Pancreatobiliary Pathology Society.
Wang H; Chetty R; Hosseini M; Allende DS; Esposito I; Matsuda Y; Deshpande V; Shi J; Dhall D; Jang KT; Kim GE; Luchini C; Graham RP; Reid MD; Basturk O; Hruban RH; Krasinskas A; Klimstra DS; Adsay V;
Am J Surg Pathol; 2022 Jun; 46(6):754-764. PubMed ID: 34889852
[TBL] [Abstract] [Full Text] [Related]
11. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer.
Sun Y; Ren D; Zhou Y; Shen J; Wu H; Jin X
Cell Death Dis; 2021 Sep; 12(10):878. PubMed ID: 34564701
[TBL] [Abstract] [Full Text] [Related]
12. Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreatic ductal adenocarcinoma.
Kameyama A; Ye J; Shimomura A; Yokohira M; Nakano-Narusawa Y; Yamakawa K; Mukai Y; Sanomura T; Okuyama H; Miyatake N; Furihata M; Tanaka C; Kitazawa R; Bando Y; Suemitsu Y; Kojima M; Mino-Kenudson M; Suzuki Y; Okano K; Matsuda Y
Pancreatology; 2021 Dec; 21(8):1506-1515. PubMed ID: 34563448
[TBL] [Abstract] [Full Text] [Related]
13. MORPHOLOGICAL DIAGNOSIS OF pancreatic NEUROENDOCRINE TUMORS (REVIEW AND CASE REPORT).
Opanasenko D; Krychevska O; Kuryk O; Zakhartseva L; Rudnytska O
Georgian Med News; 2020 Nov; (308):101-109. PubMed ID: 33395650
[TBL] [Abstract] [Full Text] [Related]
14. Potent Dual BET/HDAC Inhibitors for Efficient Treatment of pancreatic cancer.
He S; Dong G; Li Y; Wu S; Wang W; Sheng C
Angew Chem Int Ed Engl; 2020 Feb; 59(8):3028-3032. PubMed ID: 31943585
[TBL] [Abstract] [Full Text] [Related]
15. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
Guo CM; Liu SQ; Sun MZ
Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
[TBL] [Abstract] [Full Text] [Related]
16. Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma.
Okubo S; Kojima M; Matsuda Y; Hioki M; Shimizu Y; Toyama H; Morinaga S; Gotohda N; Uesaka K; Ishii G; Mino-Kenudson M; Takahashi S
Sci Rep; 2019 Nov; 9(1):17145. PubMed ID: 31748528
[TBL] [Abstract] [Full Text] [Related]
17. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer.
Jin X; Fang R; Fan P; Zeng L; Zhang B; Lu X; Liu T
J Exp Clin Cancer Res; 2019 Nov; 38(1):463. PubMed ID: 31718704
[TBL] [Abstract] [Full Text] [Related]
18. FASTKD2 promotes cancer cell progression through upregulating Myc expression in pancreatic ductal adenocarcinoma.
Fang R; Zhang B; Lu X; Jin X; Liu T
J Cell Biochem; 2020 Mar; 121(3):2458-2466. PubMed ID: 31692063
[TBL] [Abstract] [Full Text] [Related]
19. Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer.
Fan P; Zhao J; Meng Z; Wu H; Wang B; Wu H; Jin X
J Exp Clin Cancer Res; 2019 Feb; 38(1):47. PubMed ID: 30709380
[TBL] [Abstract] [Full Text] [Related]
20. B7-H3 is regulated by brd4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma.
Zhao J; Meng Z; Xie C; Yang C; Liu Z; Wu S; Wang B; Fan P; Jin X; Wu H
Int J Biochem Cell Biol; 2019 Mar; 108():84-91. PubMed ID: 30664982
[TBL] [Abstract] [Full Text] [Related]
[Next]
